Home / Poster / Development of a Physiologically Based Pharmacokinetic Model of Buspirone and Its Active Metabolite 1-(2-Pyrimidinyl)-Piperazine to Estimate Drug-Drug Interaction and Food Effect

Poster

Development of a Physiologically Based Pharmacokinetic Model of Buspirone and Its Active Metabolite 1-(2-Pyrimidinyl)-Piperazine to Estimate Drug-Drug Interaction and Food Effect

Development of a Physiologically Based Pharmacokinetic Model of Buspirone and Its Active Metabolite 1-(2-Pyrimidinyl)-Piperazine to Estimate Drug-Drug Interaction and Food Effect

Recommended for you

Redefining Regulatory Strategy with MIDD: Insights from the Draft ICH M15 Guidance

Evolving Regulatory Landscape for Model Informed Drug Development (MIDD): Impact of the Draft ICH M15 Guidance

On-Demand Webinar

Certara’s Simcyp Educational Webinar Series: Learn from A to Z of PBBM Part 2: What is the Drug Absorption Model?

Essentials of Model-informed Drug Development in Oncology

© 2025 Certara. All Rights Reserved. | Privacy policy